KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $3.4 billion.

  • Eli Lilly's Cost of Revenue rose 4028.29% to $3.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $11.1 billion, marking a year-over-year increase of 3129.01%. This contributed to the annual value of $11.1 billion for FY2025, which is 3129.01% up from last year.
  • Per Eli Lilly's latest filing, its Cost of Revenue stood at $3.4 billion for Q4 2025, which was up 4028.29% from $3.0 billion recorded in Q3 2025.
  • Eli Lilly's Cost of Revenue's 5-year high stood at $3.4 billion during Q4 2025, with a 5-year trough of $1.4 billion in Q2 2022.
  • For the 5-year period, Eli Lilly's Cost of Revenue averaged around $2.0 billion, with its median value being $1.9 billion (2021).
  • In the last 5 years, Eli Lilly's Cost of Revenue surged by 5983.63% in 2021 and then plummeted by 2676.12% in 2022.
  • Over the past 5 years, Eli Lilly's Cost of Revenue (Quarter) stood at $2.1 billion in 2021, then fell by 24.49% to $1.5 billion in 2022, then increased by 15.48% to $1.8 billion in 2023, then soared by 34.44% to $2.4 billion in 2024, then surged by 40.28% to $3.4 billion in 2025.
  • Its Cost of Revenue was $3.4 billion in Q4 2025, compared to $3.0 billion in Q3 2025 and $2.4 billion in Q2 2025.